Recent Posts

Cancer
Local Firefighter Stomps Out Head and Neck Cancer: Get Screened on April 25!
Apr 24, 2014 By Winship Cancer Institute

While the human papillomavirus (HPV) is most commonly known as a risk factor for cervical cancer in women, it is also a growing risk factor for head and neck cancers in men. According to the American Cancer Society, oral cavity and oropharyngeal cancers (tongue, tonsils, oropharynx, gums and other parts of the mouth) occur more than twice as often among men as they do among women. Tobacco and alcohol use are still the most common risk factors for all head and neck cancers, but recent studies from the Centers for Disease Control and Prevention (CDC) report that 60 to 70 percent of cancers in the throat and base on the tongue may be linked to HPV. The National Cancer Institute (NCI) states that head and neck cancers account for approximately three percent of all cancers in the U.S. Head and neck cancer includes cancers that occur in the head or neck region, ranging from the nasal [...]

Read More | (0)
Cancer
Be a Donor—Save a life!
Apr 24, 2014 By Amelia Langston, MD, Winship Cancer Institute of Emory University

Emory Bone Marrow Transplant Center logoAs medical director of the Emory Bone Marrow and Stem Cell Transplant Center at Winship, I oversee a potentially lifesaving procedure that offers hope for survival to many patients with bone marrow disorders such as leukemia, lymphoma, myelodysplastic syndrome, immune deficiency and other blood diseases. Some patients can use their own cells for the transplant, but others require a donor because their own marrow or immune system is diseased. In this sort of transplant, the patient’s sick marrow is destroyed, and replaced by the donor’s normal marrow and immune system. If it works, it can cure a person who may not have other options!

Who can be a donor?

The best bone marrow or stem cell donor is a compatible brother or sister. Unfortunately, most people who need a transplant don’t have a brother/sister match, so we have to go to the Be The Match Registry, operated by the

[...]

Read More | (0)
Cancer
Bringing the Invisible Into Georgia Classrooms
Apr 16, 2014 By Adam Marcus, PhD, Director of Emory School of Medicine-Winship Cancer Institute Integrated Cellular Imaging Core

Microscope view of cellsOn many university campuses there is a dark room that has no windows and the walls are painted black. People wearing white lab coats enter and rest their eyes on top of what I think to be one the most magnificent instruments in a science laboratory, the microscope. These microscopes, which are no bigger than a desk but can cost more than a house, rest gently on a cushion of air and serve the purpose of making the invisible world, visible. I was hooked the first time I peered into one of these microscopes. All of a sudden this entirely new and previously invisible world moved into focus right in front of me. Tiny creatures that I had apparently been living with, were visible for the first time. I eventually turned my obsession with the microscopic world into a career. I am a scientist at a major medical school and my laboratory’s research is to study how cancer cells work, with [...]

Read More | (0)
Cancer
Celebrating Volunteers at Winship
Apr 7, 2014 By Walter J. Curran Jr., MD

Winship Volunteers

This is National Volunteer Week (April 6 – 12), a great opportunity to thank the many people who volunteer their services here at Winship in order to make life better for cancer patients and their families.

On any given day, there may be 20 or more trained Winship volunteers helping patients and staff in the clinics, waiting rooms, treatment areas and Patient and Family Resource Center.  You can spot them escorting people around the building, offering snacks or companionship to patients in treatment, playing the piano in the lobby or a cello in the hallway.  They also perform many tasks behind the scenes, such as doing clerical work, keeping the resource center stocked, and providing encouragement and support through the Peer Partners program.

These Winship ambassadors can make a world of difference in a cancer patient’s day.  Our goal is to give patients the very

[...]

Read More | (0)
Cancer
5 Actions to Consider When Diagnosed with Cancer
Mar 25, 2014 By Walter J. Curran Jr., MD

5 Things to ConsiderA common symptom of a new cancer diagnosis is pure and utter bewilderment. The American healthcare system can be a confusing maze involving dozens of options and decisions. Helping someone understand what comes next is an important part of my job as an oncologist and is necessary to assure a patient’s overall wellbeing. Here are five actions to consider taking after receiving a cancer diagnosis.

  1. Get a second opinion. Before starting any cancer treatment, get at least one additional physician or team of physicians to review your case and give an opinion on both the diagnosis and possible treatment options. In fact, you may be required to get a second opinion by your insurance company. Don’t worry about offending your doctor. Getting a second opinion is a very common practice.
  2. Look for a clinical trial. Tens of thousands of people benefit each year from volunteering to
[...]

Read More | (0)
Cancer
Understanding Colorectal Cancer
Mar 18, 2014 By Dr. Bassel El-Rayes

Colon Cancer AwarenessMarch is colorectal cancer awareness month. For those who aren’t familiar with this cancer type, it encompasses cancers that begin in either the colon or the rectum. The National Cancer Institute identifies colorectal cancer as the second leading cause of cancer-related deaths in the US. The majority of these deaths are preventable with screening and early detection, and according to the American Cancer Society, the number of colorectal cancer cases has gone down due mainly to the increase in early detection of the disease through screening.

Colorectal Cancer Risk Factors

Although colorectal cancer can affect anyone, there are certain people at higher risk of developing this disease. Colorectal cancer has a higher incidence in men as compared to women and in African Americans as compared to Caucasians. The incidence of colorectal cancer increases with age with 90 percent of

[...]

Read More | (0)
Cancer
How We’re Working to Cure Multiple Myeloma
Mar 10, 2014 By Dr. Sagar Lonial

Over the past ten years, I have seen the treatment of multiple myeloma dramatically improve because of new drug therapies that have come out of clinical trials. I am now leading a clinical study to learn more about the genetic components of multiple myeloma and how we can use that knowledge to come up with better, more targeted drugs and individualized therapies for patients. I think this landmark study will lead to treatments that effect long-term remission, or even cure, from the cancer. In the CoMMpass study, launched by the Multiple Myeloma Research Foundation, we will follow 1,000 newly diagnosed patients with multiple myeloma over the course of eight years. We will study the genomic changes in their disease while they receive frontline treatments, and continue studying those changes through remission stages or relapse. One of the questions we hope to answer is why some [...]

Read More | (0)
Cancer
Phase I Trials – Where All Anticancer Drugs Begin
Feb 27, 2014 By R. Donald Harvey, PharmD, FCCP BCOP, director of the Winship Cancer Institute of Emory University’s Phase I Clinical Trials section

Donald Harvey, MD

R. Donald Harvey, PharmD, FCCP BCOP, director of the Winship Cancer Institute of Emory University’s Phase I Clinical Trials section

Each of the agents we use to treat cancer had a beginning, a first step, in understanding how safe and effective they might be.  As drugs are developed, we ask questions in different ways at each step, or phase, of testing. The National Cancer Institute reminds us that clinical trials are available for all patients at all points in their cancer journey, not just for patients with advanced cancer that is not responding to treatment.

When a drug is first given to patients, it enters testing in a phase I trial, where we ask questions such as:

  • What is the right dose?
  • How should it be given (e.g., by mouth, by vein, under the skin)?
  • What is the right schedule of treatment?
  • What side effects are there and how severe are they?
  • How often
[...]

Read More | (0)
Cancer
Understanding Multiple Myeloma
Feb 21, 2014 By Dr. Sagar Lonial

While still a relatively uncommon cancer, multiple myeloma has recently received attention surrounding the diagnosis of popular news reporter, Tom Brokaw. This year, an estimated 24,000 people in the United States will be diagnosed with multiple myeloma, and there are about 77,600 people now living with this blood cancer.

About Multiple Myeloma

Multiple myeloma is a type of cancer that forms because of a disorder in the plasma cells, which live in the bone marrow and are the producers of antibodies. These antibodies are what provide protection from infections after vaccination, but in myeloma, the plasma cells become malignant and grow out of control, crowding out the normal bone marrow.

When plasma cells grow uncontrolled by the normal immune system, the consequences can include:

  • Anemia, a condition caused by low red blood cell counts due to crowding in the bone
[...]

Read More | (2)
Cancer
Winship Cancer Institute Launches New Ad
Feb 19, 2014 By Winship Cancer Institute

As you’re watching the Winter Olympics this month, keep an eye out for a new television ad spotlighting the Winship Cancer Institute of Emory University. The 60-second commercial depicts aging fighter jets as a metaphor for outdated cancer treatment. In contrast, Winship offers state-of-the-art care to tens of thousands of cancer patients every year. As Georgia’s only National Cancer Institute-Designated Cancer Center, Winship serves the citizens of the Southeast by working tirelessly to prevent, treat and cure cancer. Patients are offered integrative, multi-disciplinary care that they could not receive anywhere else in the state. The ad notes that over the past seven years, Winship has led or participated in clinical trials for over 75-percent of new FDA-approved cancer treatments. Last fall, Emory Healthcare began running a series of ads that look at what’s [...]

Read More | (0)